[Lanadelumab : Future plasma-independent subcutaneous prophylaxis for bradykinin-mediated angioedema?]
Hautarzt
.
2017 Jul;68(7):585-587.
doi: 10.1007/s00105-017-3991-7.
[Article in German]
Author
B Wedi
1
Affiliation
1
Klinik für Dermatologie, Allergologie und Venerologie, Comprehensive Allergy Center (CAC), Medizinische Hochschule Hannover, Carl-Neuberg-Str. 1, 30625, Hannover, Deutschland. wedi.bettina@mh-hannover.de.
PMID:
28560465
DOI:
10.1007/s00105-017-3991-7
No abstract available
MeSH terms
Angioedema*
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
Bradykinin*
Humans
Substances
Antibodies, Monoclonal
Antibodies, Monoclonal, Humanized
lanadelumab
Bradykinin